Targeting Metabolic Enzymes in Cancer – Clinical Trials Update

Publisher： Bentham Science Publishers

E-ISSN： 1875-6662|9|2|152-160

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.9, Iss.2, 2013-09, pp. : 152-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on anti-CTLA-4 antibodies in clinical trials

By Langer Lee F   Clay Timothy M   Morse Michael A  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 8, 2007-08 ,pp. : 1245-1256

Informa Healthcare

Access to resources Recommend Favorite

Impaired Expression and Function of Cancer-Related Enzymes by Anthocyans: An Update

By  

Current Enzyme Inhibition, Vol. 8, Iss. 1, 2012-05 ,pp. : 2-21

Bentham Science Publishers

Access to resources Recommend Favorite

Breast cancer prevention-clinical trials strategies involving aromatase inhibitors

By Goss P.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 487-493

Elsevier

Access to resources Recommend Favorite

A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J   Nemunaitis J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

By Derosa Giuseppe   Maffioli Pamela   Cicero Arrigo FG  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1113-1124

Informa Healthcare

Access to resources Recommend Favorite